SET SAIL FOR NEW HORIZONS ON THE 40TH ANNIVERSARY• 揚帆追夢-澳門大學40週年 推動科技成果轉化• PROMOTING TECHNOLOGY TRANSFER 2021 UMAGAZINE 23•澳大新語 澳大新語•2021 UMAGAZINE 23 36 37 近年，澳大更聯合北京大學天然藥物及 仿生藥物國家重點實驗室和粵澳合作中 醫藥科技產業園，共同建立「中華醫藥 創新科技轉移平台」。在粵港澳大灣區 發展機遇下，澳大通過打造橫琴產學研 示範基地以及聯動粵澳合作中醫藥科技 產業園，推動中醫藥研發在橫琴的佈局 和發展，並努力與大灣區知名藥企推進 經典名方與配方顆粒的研發、註冊和產 業轉化，合力推動中醫藥標準化與國際化。 智慧城市物聯網科研成果 澳大在智慧城市物聯網方面的科研也日 趨成熟，2010年澳大教授和內地專家 組成團隊，開展「物聯網基礎理論及 設計方法研究」項目，獲國家重點基 礎研究發展計劃（973計劃）立項和資 助。2018年，澳大獲國家科學技術部 批准設立智慧城市物聯網國家重點實驗 室，由現任校長、國際知名電力系統專 家宋永華教授出任主任。 UM has won numerous local, national, and international awards for its achievements in Chinese medicine research. In 2016, a research project using DNA barcoding technology to identify the species of medicinal plants, conducted by UM, Peking Union Medical College, and several other institutions, received a second prize of the State Scientific and Technological Progress Award. In 2019, two inventions developed by a group of researchers from the SKL‑QRCM—one is a series of innovative Chinese herbal products and the other is a zebrafish screening system based on microfluidic technology— won gold awards at the 47th International Exhibition of Inventions of Geneva. The former project included six products in two forms: solid‑liquid capsule form and granule form. It was the first time that a modern Chinese herbal product from Macao won this award. In collaboration with Peking University’s State Key Laboratory of Natural and Biomimetic Drugs and the Traditional Chinese Medicine Science and Technology Industrial Park jointly established by Guangdong and Macao (the Industrial Park), UM has established a platform for the commercialisation of new technologies in Chinese medicine. Seizing the opportunities brought 在研究院時任院長王一濤教授率領的 澳門中醫藥學者團隊努力下，中藥質量 研究國家重點實驗室在2011年掲牌， 是全國首個中醫藥領域的國家重點實驗 室。2012年，澳大與美國藥典委員會 就中藥標準聯合實驗室簽署協議，成為 全球首間與該委員會建立中藥質量標準 開發合作實驗室的高等院校。目前，澳 大已完成美國藥典及歐洲藥典等10多項 中藥標準。 澳大的中醫藥研究在本地、全國和國 際場合屢獲殊榮。2016年，澳大與 北京協和醫學院—清華大學醫學部等 完成的「中草藥DNA條形碼物種鑒定 體系」獲得國家科學技術進步獎二等 獎。2019年，澳大研發的「創新中藥系 列產品」和「基於微流控技術的斑馬魚篩 選系統」在第47屆日內瓦國際發明展獲 頒「發明金獎」，前者包括中藥固液膠 囊和新型顆粒劑兩個系列共六個產品， 是澳門首個獲此殊榮的「現代中藥」創 新產品。 Achievements in Chinese Medical Sciences Chinese medical sciences is another research area in which UM has achieved impressive results. For instance, the university has developed many innovative drugs and health products, and has participated in the development of pharmacopoeial conventions for Chinese medicine in Europe and the United States, creating favourable conditions for Chinese medicine to enter the international market. In 2002, UM established the Institute of Chinese Medical Sciences (ICMS). With the joint effort of a team of Chinese medicine scholars in Macao, led by Prof Wang Yitao, then director of ICMS, the State Key Laboratory of Quality Research in Chinese Medicine (SKL‑QRCM) was officially inaugurated in 2011 and became the first state key laboratory of Chinese medicine in China. In 2012, UM signed an agreement with the United States Pharmacopeial Convention for the establishment of a joint laboratory. It was the first time that the organisation collaborated with a higher education institution in establishing quality standards for Chinese medicine. So far, UM has completed more than ten Chinese medicine standards, including those in the US Pharmacopeia and the European Pharmacopeia. 澳門首台自動駕駛巴士在澳大校園啟用 Macao’s first autonomous bus becomes operational on the UM campus 澳大獲國家批准於2011年設立模擬與混合信號超大規模集成電路國家重點實驗室及中藥質量研究國家重點實驗室 In 2011, UM receives approval from the central government to establish two state key laboratories, namely the State Key Laboratory of Analog and Mixed‑Signal VLSI, and the State Key Laboratory of Quality Research in Chinese Medicine.
RkJQdWJsaXNoZXIy NzM0NzM2